Abstract
Purine nucleoside phosphorylase (PNP), an enzyme involved in the catabolism and recycling of nucleosides, is under investigation for the development of novel antibiotics. One method used for the design of inhibitors is transition state analysis. Chemically stable analogues of a transition state complex are predicted to convert the energy of enzymatic rate acceleration (kcat/knon) into binding energy. Transition state structures have been reported for the bovine (Bos taurus), human (Homo sapiens), and malarial (Plasmodium falciparum) PNPs. All three enzymes proceed through SN1-like mechanisms and have transition states with substantial ribooxocarbenium ion character. Bovine PNP proceeds through an early SN1-like transition state, whereas the human and malarial PNPs proceed through more dissociative transition state. Transition state analogues developed for PNP exhibit differential inhibition specificity for these three enzymes based upon their distinct reaction rates (kcat), mechanisms, and substrate specificity. The most powerful inhibitors of these three enzymes have picomolar dissociation constants, two of which are Immucillin-H and DADMe-Immucillin-H. MTImmucillin- H was also developed as a specific inhibitor for P. falciparum PNP by virtue of its unique utilization of 5- methylthio substrates. Although the transition state for tuberculosis (Mycobacterium tuberculosis) PNP is yet to be determined, inhibition values support a mechanism with a dissociative transition state like those of its human and plasmodial counterparts. Comparison of the transition states and substrate specificity of various PNPs permits the design of species-specific inhibitors for use as therapeutic agents.
Keywords: purine nucleoside phosphorylase, transition state analogue, inhibitor, kinetic isotope effects, Immucillin, dadme-Immucillin, malaria, t-cell disorders
Current Topics in Medicinal Chemistry
Title: Transition States and Inhibitors of the Purine Nucleoside Phosphorylase Family
Volume: 5 Issue: 13
Author(s): Erika A. T. Ringia and Vern L. Schramm
Affiliation:
Keywords: purine nucleoside phosphorylase, transition state analogue, inhibitor, kinetic isotope effects, Immucillin, dadme-Immucillin, malaria, t-cell disorders
Abstract: Purine nucleoside phosphorylase (PNP), an enzyme involved in the catabolism and recycling of nucleosides, is under investigation for the development of novel antibiotics. One method used for the design of inhibitors is transition state analysis. Chemically stable analogues of a transition state complex are predicted to convert the energy of enzymatic rate acceleration (kcat/knon) into binding energy. Transition state structures have been reported for the bovine (Bos taurus), human (Homo sapiens), and malarial (Plasmodium falciparum) PNPs. All three enzymes proceed through SN1-like mechanisms and have transition states with substantial ribooxocarbenium ion character. Bovine PNP proceeds through an early SN1-like transition state, whereas the human and malarial PNPs proceed through more dissociative transition state. Transition state analogues developed for PNP exhibit differential inhibition specificity for these three enzymes based upon their distinct reaction rates (kcat), mechanisms, and substrate specificity. The most powerful inhibitors of these three enzymes have picomolar dissociation constants, two of which are Immucillin-H and DADMe-Immucillin-H. MTImmucillin- H was also developed as a specific inhibitor for P. falciparum PNP by virtue of its unique utilization of 5- methylthio substrates. Although the transition state for tuberculosis (Mycobacterium tuberculosis) PNP is yet to be determined, inhibition values support a mechanism with a dissociative transition state like those of its human and plasmodial counterparts. Comparison of the transition states and substrate specificity of various PNPs permits the design of species-specific inhibitors for use as therapeutic agents.
Export Options
About this article
Cite this article as:
Ringia A. T. Erika and Schramm L. Vern, Transition States and Inhibitors of the Purine Nucleoside Phosphorylase Family, Current Topics in Medicinal Chemistry 2005; 5 (13) . https://dx.doi.org/10.2174/156802605774463088
DOI https://dx.doi.org/10.2174/156802605774463088 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Invasive Immunization on the Skin Using DNA Vaccine
Current Drug Delivery Artificial Intelligence Approaches for Rational Drug Design and Discovery
Current Pharmaceutical Design p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Bioinformatics The Influence of Cigarette Smoking on Sperm Quality and Sperm Membrane Integrity
Current Women`s Health Reviews LC-MS/MS Assay for Quantification of a Novel Antitubercular Molecule S006-830: Pharmacokinetic and Plasma Protein Binding Studies in Rats
Current Pharmaceutical Analysis Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design Nanotechnology-Based Approaches for Combating Tuberculosis: A Review
Current Nanomaterials Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Synergistic Interplay of The Co-administration of Rifampin And Newly Developed Anti-TB Drug: Could It Be a Promising New Line of TB Therapy?
Combinatorial Chemistry & High Throughput Screening Antimycobacterial Activities of Oxazolidinones: A Review
Infectious Disorders - Drug Targets Preface [Hot topic: Carbohydrates (Executive Editor: Istvan Toth)]
Mini-Reviews in Medicinal Chemistry Antibody - Fc Receptor Interactions in Antimicrobial Functions
Current Immunology Reviews (Discontinued) Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Using Xpert MTB/RIF
Current Respiratory Medicine Reviews Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery
Current Pharmaceutical Design Recombinant Salmonella Vaccination Technology and Its Application to Human Bacterial Pathogens
Current Pharmaceutical Biotechnology Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry